[go: up one dir, main page]

ES2137137A1 - Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica. - Google Patents

Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.

Info

Publication number
ES2137137A1
ES2137137A1 ES009801078A ES9801078A ES2137137A1 ES 2137137 A1 ES2137137 A1 ES 2137137A1 ES 009801078 A ES009801078 A ES 009801078A ES 9801078 A ES9801078 A ES 9801078A ES 2137137 A1 ES2137137 A1 ES 2137137A1
Authority
ES
Spain
Prior art keywords
gabapentine
polymorph
hydrated
utilization
production process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009801078A
Other languages
English (en)
Other versions
ES2137137B1 (es
Inventor
Llado Jordi Bosch
Cruz Rafael Garcia
Grau Elias Molins
Miguel M Carmen Conrubia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medichem SA
Original Assignee
Medichem SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES009801078A priority Critical patent/ES2137137B1/es
Application filed by Medichem SA filed Critical Medichem SA
Priority to CA002333408A priority patent/CA2333408A1/en
Priority to PCT/ES1999/000127 priority patent/WO1999061408A1/es
Priority to AU37106/99A priority patent/AU3710699A/en
Priority to DE69912773T priority patent/DE69912773T2/de
Priority to EP99919275A priority patent/EP1083164B1/en
Priority to HU0102104A priority patent/HUP0102104A3/hu
Priority to IL13981799A priority patent/IL139817A/xx
Priority to US09/700,939 priority patent/US6521787B1/en
Publication of ES2137137A1 publication Critical patent/ES2137137A1/es
Application granted granted Critical
Publication of ES2137137B1 publication Critical patent/ES2137137B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtención y su utilización para la obtención de gabapentina de calidad farmacéutica; se describe un nuevo polimorfo de gabapentina no hidratada, obtenido mediante la desecación por atomización o turbo-secado de una disolución acuosa de gabapentina, y su utilización para obtener gabapentina apta para su uso farmacéutico mediante un procedimiento consistente en someter dicho nuevo polimorfo a un proceso de cristalización en disolventes.
ES009801078A 1998-05-25 1998-05-25 Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica. Expired - Fee Related ES2137137B1 (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ES009801078A ES2137137B1 (es) 1998-05-25 1998-05-25 Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
PCT/ES1999/000127 WO1999061408A1 (es) 1998-05-25 1999-05-10 Polimorfo de gabapentina no hidratada, procedimiento para su obtención y su utilización para la obtención de gabapentina de calidad farmacéutica
AU37106/99A AU3710699A (en) 1998-05-25 1999-05-10 Non-hydrated gabapentine polymorph, production process and utilization for producing pharmaceutical grade gabapentine
DE69912773T DE69912773T2 (de) 1998-05-25 1999-05-10 Nicht hydratisiertes gabapentin polymorph, herstellungsprozess und verwendung zur herstellung von gabapentin pharmazeutischer reinheit.
CA002333408A CA2333408A1 (en) 1998-05-25 1999-05-10 Non-hydrated gabapentin polymorph, a process for the preparation thereof and the use therefor for the preparation of pharmaceutical grade gabapentin
EP99919275A EP1083164B1 (en) 1998-05-25 1999-05-10 Non-hydrated gabapentin polymorph, production process and utilization for producing pharmaceutical grade gabapentin
HU0102104A HUP0102104A3 (en) 1998-05-25 1999-05-10 Non-hydrated gabapentine polymorph, production process and utilization for producing pharmaceutical grade gabapentine
IL13981799A IL139817A (en) 1998-05-25 1999-05-10 Non-hydrated gabapentin polymorpha process for thepreparation thereof and the use thereof for the p reparation of pharmaceutical grade gabapentin
US09/700,939 US6521787B1 (en) 1998-05-25 1999-05-10 Non-hydrated gabapentine polymorph, production process and utilization for producing pharmaceutical grade gabapentine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009801078A ES2137137B1 (es) 1998-05-25 1998-05-25 Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.

Publications (2)

Publication Number Publication Date
ES2137137A1 true ES2137137A1 (es) 1999-12-01
ES2137137B1 ES2137137B1 (es) 2000-08-16

Family

ID=8303893

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009801078A Expired - Fee Related ES2137137B1 (es) 1998-05-25 1998-05-25 Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.

Country Status (9)

Country Link
US (1) US6521787B1 (es)
EP (1) EP1083164B1 (es)
AU (1) AU3710699A (es)
CA (1) CA2333408A1 (es)
DE (1) DE69912773T2 (es)
ES (1) ES2137137B1 (es)
HU (1) HUP0102104A3 (es)
IL (1) IL139817A (es)
WO (1) WO1999061408A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60022333T2 (de) 1999-04-09 2006-07-06 Euro-Celtique S.A. Natrium kanalblocker zusammensetzungen und deren verwendung
ES2164527B1 (es) * 1999-04-26 2003-04-01 Medichen S A Procedimiento de obtencion de gabapentina de calidad farmaceutica.
RU2295337C2 (ru) 2001-09-03 2007-03-20 Ньюрон Фармасьютикалс Спа Фармацевтическая композиция, содержащая габапентин или его аналог и альфа-аминоамид, и ее применение в качестве анальгетика
US6800782B2 (en) 2001-10-09 2004-10-05 Warner-Lambert Co. Anhydrous crystalline forms of gabapentin
ITMI20022071A1 (it) * 2002-10-01 2004-04-02 Erregierre Spa Processo di sintesi dell'acido 1-(aminometil)cicloesanacetico cloridato.
KR20050086519A (ko) * 2002-11-12 2005-08-30 티안진 킨슬리 파마슈티컬 컴퍼니 리미티드 새로운 결정 형태를 가진 아데포비어 디피복실 및 그조성물
WO2004106281A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Crystalline gabapentin
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
US20050187295A1 (en) * 2004-02-19 2005-08-25 Surendra Kalyan Processes for the preparation of gabapentin
WO2009019661A1 (en) * 2007-08-07 2009-02-12 Ranbaxy Laboratories Limited Process for preparation of amorphous lopinavir
AU2010210467A1 (en) * 2009-02-06 2011-08-18 Bach Pharma, Inc. Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them
RU2650511C2 (ru) 2012-05-17 2018-04-16 Дженентек, Инк. Формы и составы пиримидинилциклопентанового соединения, композиции и способы, относящиеся к ним

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891A1 (de) * 1974-12-21 1976-07-01 Goedecke Ag Cyclische aminosaeuren
US4960931A (en) * 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
US5068413A (en) * 1989-08-25 1991-11-26 Godecke Aktiengesellschaft Process for the preparation of cyclic amino acids and intermediates useful in the process
WO1998028255A1 (en) * 1996-12-24 1998-07-02 Teva Pharmaceutical Industries Ltd. Preparation of gabapentin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
US4894476A (en) 1988-05-02 1990-01-16 Warner-Lambert Company Gabapentin monohydrate and a process for producing the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891A1 (de) * 1974-12-21 1976-07-01 Goedecke Ag Cyclische aminosaeuren
US4024175A (en) * 1974-12-21 1977-05-17 Warner-Lambert Company Cyclic amino acids
US4960931A (en) * 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
US5068413A (en) * 1989-08-25 1991-11-26 Godecke Aktiengesellschaft Process for the preparation of cyclic amino acids and intermediates useful in the process
WO1998028255A1 (en) * 1996-12-24 1998-07-02 Teva Pharmaceutical Industries Ltd. Preparation of gabapentin

Also Published As

Publication number Publication date
EP1083164B1 (en) 2003-11-12
ES2137137B1 (es) 2000-08-16
HUP0102104A2 (hu) 2001-11-28
US6521787B1 (en) 2003-02-18
EP1083164A1 (en) 2001-03-14
AU3710699A (en) 1999-12-13
IL139817A (en) 2005-11-20
DE69912773D1 (de) 2003-12-18
DE69912773T2 (de) 2004-09-30
WO1999061408A1 (es) 1999-12-02
HUP0102104A3 (en) 2002-11-28
IL139817A0 (en) 2002-02-10
CA2333408A1 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
ES2137137A1 (es) Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
WO1997011029A3 (en) Polyaluminum chlorides and polyaluminum chlorosulfates methods and compositions
AP1668A (en) Method for separating hemicelluloses from a biomass containing hemicelluloses and biomass and hemicelluloses obtained by said method.
HU905333D0 (en) Process for producing cyclic amino-acid derivatives
HUP0102465A2 (hu) Eljárás peroxikarbonsav-monoészter vizes oldatának előállítására, az eljárással előállított oldat és alkalmazása fertőtlenítőszerként
TW200510439A (en) Improved crystalline form of sucralose, and method for producing it
CA2299475A1 (en) Method for producing an aqueous solution of free hydroxylamine
BG100942A (en) Method for the production of nicotinic acid amide
DK0737210T3 (da) Fremgangsmåde til fremstilling af kationisk stivelse
MXPA03005640A (es) Proceso continuo para producir acido l-ascorbico.
MY119738A (en) Process for the purification of an alkanolamine
ATE344785T1 (de) Verfahren zur herstellung von hochreinen stabilisierten hydroxylaminlösungen
HUP0104345A2 (hu) Eljárás ammónium-szulfát tisztítására
MX9708774A (es) Procedimiento para la fabricacion de sal de acido clavulanico.
EP1371733A4 (en) METHOD OF PREPARING HYALURONIC ACID OR ITS DERIVATIVES
HUP0102562A2 (hu) Expressziós vektor egyetlen lépésből álló tisztítási eljárásban történő alkalmazásra
NO985489L (no) FremgangsmÕte for fremstilling av nikotinsyre
CA2293319A1 (en) Method for producing highly pure aqueous hydroxylamine solutions
DE50101761D1 (de) Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäure
TW347383B (en) A process for the production of a crystalline sodium salt of amoxicillin in ethanol as solvent
PT1200640E (pt) Processo de revestimento
WO2002032235A3 (en) Process for making mineral, food or pharmaceutical grade salt products
EP1072585A3 (en) Process for producing dimethylcyanamide
MA23095A1 (fr) Procede de production du sel de lysine du 6-chloro-5-fluoro -3- (2-thenoyl)-2-oxindole-1-carboxamide .
HU0800403D0 (en) Process for producing enantiomers of (1s,4r)- or (1r,4s)-1-amino-4-hydroxymethyl-2-cyclopentene derivatives

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19991201

Kind code of ref document: A1

Effective date: 19991201

FD1A Patent lapsed

Effective date: 20101018